Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh
Showing posts with label prostitution. Show all posts
Showing posts with label prostitution. Show all posts

Thursday, April 7, 2016

"Fuck You", Bayer Essure!


The Controversial Birth Control That Destroys Your Body



APR 6 2016 4:55 PM



COURTESY OF BAYER

Despite thousands of women's complaints about Essure—ranging from uterus perforation to miscarriage—the FDA allows the birth control device to remain on the market. Jessica Smith describes how her Essure implant turned her body against her.
Jessica Smith's unedited, angry comment is still on the FDA's website, much to her surprise. "You had an opportunity to remove Essure from the market. You blew it," it reads. Despite complaints from women who say they've experienced painful and severe side effects such as constant cramping, still births, ectopic pregnancies, and miscarriages from the sterilization implant Essure, the Food and Drug Administration has so far allowed drug maker Bayer AG to continue to selling its product.
"Like all forms of birth control, Essure is not perfect and women may become pregnant despite use of the device," Dr. William Maisel, the FDA's Center for Devices and Radiological Health director, said in a statement. Due to multiple lawsuits regarding Essure and a recent congressional investigation, the FDA announced in February that it would place a "black box" warning on Essure and order Bayer AG to conduct more safety studies on the device.
In the meantime, as Essure remains for sale but under federal review, the FDA has invited patients to leave public comments on its website about their experience with the controversial birth control implant. "You could have allowed us the opportunity to be compensated for our horribly damaged bodies, careers, relationships and lives. But you didn't. You blew it," Jessica's post goes on. "You blew it worse than the sex workers blew your Deputy for science at the FDA Center of Devices and Radiological Health back in 2012," she ends the post, crudely referencing the 2012 arrest of the FDA's Maisel in an alleged prostitution sting.
Jessica keeps a cheerful face on, but, like other woman who complain about Essure, she is also clearly bitter. She developed a painful condition called pelvic adhesion disease, in which her reproductive system is fused to her digestive system due to scar tissue. She and her doctors believe this is a result of the Essure implant.
In an interview at her apartment in North Texas, joined by two of her close friends, Jessica showed Broadly her extensive medical records and described the chaotic process of trying to find a doctor who might be able to "fix" her.

Jessica at home
After Jessica gave birth to fifth baby in 2013, she decided to go on a more permanent form of birth control. She considered her options: She could have had her "tubes tied,"—known medically as tubal ligation, the older and more common form of female sterilization—but she decided not to because she had no guaranteed paid sick days left to recover from surgery. Essure then seemed to be the more practical choice; Bayer AG claims that, unlike tubal ligation, Essure is a not a surgery but a quick, non-invasive outpatient procedure. Jessica says her doctor told her the recovery time would be a day.


She says she felt the pain immediately as her doctor implanted the device. She remembers being told to take an Advil. "She's a really conservative doctor, so the impression I had is she thought I was being kind of a weenie," Jessica recalls.
When Jessica got home that night, she says she started passing large tissue. According to Jessica, the nurse on call "said that sounded normal and I didn't need to come back to the doctor for that. And I was like, 'If that's normal, why isn't that one of the side effects listed?'"
You had an opportunity to remove Essure from the market. You blew it worse than the sex workers blew your Deputy for science at the FDA Center of Devices and Radiological Health back in 2012.
The bleeding didn't stop. Not for 10 months. Jessica says that she felt as though she was on her period through the entire 10-month span. She felt a constant pain in her abdomen, which vacillated between feeling bearable to being so intense that she could not stand, and therefore couldn't work.
She made regular trips to the emergency room. Doctors at the E.R. diagnosed her with vague conditions like "abdominal pain" and told her to return to her implanting physician. "I would hang my hat that you have an STD," she remembers one doctor telling her.
Another told her she was suffering from the "period from hell" and prescribed her hormonal birth control pills. Doctors gave her forms about things that cause pelvic pain—conditions like STDs, fibromyalgia, and endometriosis. Nothing pointed to Essure. "Their findings didn't show anything wrong. How can you treat what's not wrong?" she says.

Elizabeth Fluegge, another Essure victim who needed to have her device surgically removed










Jessica returned to her gynecologist's office, where they couldn't find anything wrong, either. At one appointment, she says, her implanting physician's partner "accused me of being a pill seeker and said it's not possible for Essure to hurt because it's so small." In the same breath, however, Jessica says the doctor told her that, unlike her partner, she does not implant Essure, "because leaving metal in soft tissue is not a good idea.'"


The retailer where Jessica works initially denied her paid sick leave but then gave her the days retroactively, allowing her to support herself and her children on the days that she was in too much pain to work. Jessica eventually realized that the pain was at its worst during the time in her cycle when she was ovulating and when she was menstruating.
A year later Jessica found what she believed would be a long-term solution to her pain: a relatively unknown surgery called "Essure reversal." So-called Essure reversals are expensive, complicated procedures performed by fertility doctors; they're not covered by insurance. They promise the woman the chance to get their Essure removed from their body without undergoing a drastic hysterectomy procedure. What's more, doctors who perform Essure reversals say that women who previously had Essure may even be able to get pregnant again.
Jessica chose a doctor in Florida, who charged $6,000 for the procedure. "He said a third of his patients get pregnant afterward," Jessica says. Jessica's fiancée took out a medical loan from a financial firm the doctor conveniently provided a link to on his website. Initially the surgery seemed to cure her pain.
But the relief didn't last, and the pain returned. "It would be kind of intermittent, and then the periods of pain would be longer and longer until I was just in pain all the time again," she says.
In Austin, Jessica visited a new doctor—one who has become popular with Essure patients for offering them advice on Facebook and setting aside time at his practice to meet with them. When he examined Jessica, she says, she was in so much pain he warned her that he may not be able to help. "There isn't a recognized safe method to remove Essure," Jessica says. "So basically it's just doctors making stuff up without much oversight or regulation or anything."
The doctor told her he could remove the scar tissue causing her pain, but that it may grow back, and if it did, she would need to see a different doctor to perform the next, more technically complicated surgery. Jessica took the gamble and underwent her second post-Essure surgery with him anyway.


Jessica's ovaries, the doctor's report explained, were attached to her pelvic side walls, and "her right ovary [had] a significant attachment to the colon.
"The patient, upon inspection of the pelvis, had extensive adhesive disease of the colon and small bowel... she also had severe pelvic disease from the top of fundus down to the endocervix," reads the doctor's surgical report, which Jessica saved. Jessica's ovaries, his report explained, were attached to her pelvic side walls, and "her right ovary [had] a significant attachment to the colon."
This surgery, like the last, only gave Jessica temporary relief. In pain and missing more work again, Jessica searched for another doctor and found one who still implants Essure in women but who also took her pain seriously.
On March 22, she scheduled her third post-Essure surgery. Beforehand, her doctor told her he would not perform a hysterectomy unless it was absolutely necessary.
"Out of surgery," Jessica texted me the next day. "I had a hysterectomy. "They took my uterus, cervix and tubes. I'm sad... This is not what I wanted. We are still paying for my reversal."
Her doctor had found so much scar tissue that he had little choice but to remove much of her organs. "He told me that Essure works very well for most women. Just not for me," she says. "'And 28,000 other women,' I said, because I am relentless."
Now Jessica is recovering and hoping to return to work. She recently busted a stitch open in her belly button after hiding Easter eggs with her children, but says it's otherwise going okay. She still has her job and is waiting for word on if her disability leave will be covered during her recovery time. In the meantime, she has joined a lawsuit against Bayer AG. Though the company's special FDA approval bars it from lawsuits, attorneys are attempting to sue the company anyway, and they recently won a surprising, minor success from a judge who allowed two claims against the company to go forward.



Jessica also leans on her friends for support. Her two friends and coworkers who sat in the interview with her have taken her to the hospital or watched her children when she was in too much pain to stand. And, in an effort to help Jessica with her medical bills, they even organized a surprise fundraiser last month, complete with a band and dozens of vendors at a local bar. The name of their event, written out in all-caps on the marquis of the bar, summed up the attitude that Jessica has about the last past two years of her life: "FUCK YOU, ESSURE."

Wednesday, September 23, 2015

FDA has a 'hearing problem'. Harmed patients (women) amplify social media voice!



FDA Reviews Essure to See if Device Causes Problems

by REUTERS  9/23, 2015
U.S. health experts will review the potential risks of Bayer AG's permanent contraceptive device, Essure, on Thursday in light of growing complaints over possible side effects, and consider whether its use should be restricted.
Some 17,000 women who had the device implanted and claim it has hurt them are members of the Facebook group "Essure Problems," run by Angela Lynch, who herself experienced problems with Essure. Complaints voiced by the women include chronic pain, heavy bleeding, fatigue and skin allergies.
The Food and Drug Administration panel will be asked to discuss potential changes to the product's label and whether further clinical studies should be conducted. The panel will not be asked to formally vote on their recommendations.
Bayer obtained the device with its $1.1 billion acquisition of Conceptus in 2013 and maintains it is safe and effective. It says roughly 750,000 units have been sold, mostly in the United States.
It's a small metal spring that goes into the fallopian tubes - an alternative to tying them.
Dr. Patricia Carney, the company's medical director for Essure, said the company welcomes the discussion.
"We want to understand as a company what is going on," she said. "We want to know whether there is a link to the product."
Already the complaints have led some physicians to re-examine their use of the device.
Dr. Sebastiaan Veersema, a gynecologist at St. Antonius Hospital Nieuwegein in the Netherlands, was an early European adopter, implanting the device in nearly 1,400 women and training dozens of practitioners in its use.
He now believes more research needs to be done to establish what, if any, relationship exists between the device and the problems relayed by some patients.
"If there is something wrong with the device I want to know," he said.
Veersema said a stronger screening process might be warranted to avoid implanting Essure in women who already have a uterine problem, such as fibroids.
Angela Lynch was 28 when she was implanted with the device. She had three children and did not want any more.
"Because I had just had a kid I wrote off all my symptoms as hormonal, my body trying to adjust," she said. "After two years I started losing hair. Then I started losing teeth, and over time it got to where my whole body was hurting."
In 2012 she had the device removed and underwent a hysterectomy.
"After three days it was like I woke up from a five-year flu," she said.
Dr. Cindy Basinski, who consults for Bayer and will be testifying on the company's behalf at the FDA meeting, has been implanting the device since 2006 and has conducted about 1,100 procedures with minimal complications.
She has had "a couple" of patients come to her with complaints and one asked for the device to be removed.
Basinski, who practices in Newburgh, Indiana, said she in "no way discounts the patients out there recounting their experience," but said it was not possible to draw scientific conclusions from anecdotal information.
For some doctors, it is not just the implantation of the device that needs to be looked at but how it is removed.
Dr. Shawn Tassone, who practices at a clinic in Austin, Texas, began implanting Essure in 2008, said there is no standardized method for removal.
"I'm hoping that all this will change the way doctors counsel their patients," Tassone said. "Instead of saying Essure is an easy procedure with no side effects, (they should) say this is a surgery and there are people reporting complications." 
http://www.nbcnews.com/health/womens-health/fda-reviews-essure-see-if-device-causes-problems-n432351

Friday, November 2, 2012

High Standards for FDA leaders?




                Police & Fire
William Maisel is one of three men who pleaded guilty to charges of soliciting prostitution during a sting carried out by the Howard County Police Department.
                By Brian Hooks
                September 25, 2012

Dr. William Maisel, the cardiologist and Food and Drug Administration (FDA) official charged by the Howard County Police Department in July with soliciting a prostitute, recently pleaded guilty in district court.

Maisel is the deputy director of the Center for Devices and Radiological Health (CDRH), which has become embroiled in an employee-spying scandal. He received one day of probation and paid $257.50 in fees and courts costs, according to T. Wayne Kirwan, spokesperson for the Howard County State's Attorney's Office.

Maisel's one day of probation ended on Friday, Sept. 21, according to Kirwan.  

According to charging documents from district court, an undercover female police officer approached Maisel at a restaurant on Route 1 in Jessup and asked him if he wanted "a date." Maisel agreed and asked how much it would cost for sex.
Three of the other men arrested in the prostitution sting also pleaded guilty and received probation, according to Kirwan, but only one faces probation longer than two days. Five additional men charged are still facing court dates.  

In a matter unrelated to Maisel's arrest, the National Whistleblower Center (NWC) is asking whether the charges against him are indicative of his involvement in the FDA surveillance activity, reports The Washington Post.  

According to the NWC, Maisel was responsible for firing Ewa Czerska–one of the FDA employees observed in the surveillance–and the whistleblowers are asking whether Maisel's work will be investigated, reports The Post.  

FDA spokesperson Erica Jefferson told The Post that the administration considers the solicitation charges "a personal matter" that would not affect his work.



Larry Husten, Contributor to Forbes
PHARMA & HEALTHCARE | 8/01/2012 @ 3:34PM
Cardiologist William Maisel, the deputy director for science at the FDA Center of Devices and Radiological Health, was arrested on prostitution charges after being caught in an undercover sting operation in North Laurel, Maryland. Maisel was one of 10 men arrested on July 13.
The Savage-Guilford Patch reported that Maisel ”approached a plain-clothed female police officer and offered money for sex.” He is scheduled to appear in Howard County District Court on Sept. 20.
According to Pharmalot, the news ”was greeted with a mixture of shock and sadness inside the FDA, which is treating the incident as a personal matter, according to an FDA spokeswoman. The arrest, she tells us, ‘has nothing to do with the work he is doing here.’” Maisel did not respond to a request for comment from Pharmalot.
Prior to joining the FDA Maisel had been the director of the Medical Device Safety Institute at Beth Israel Deaconess Medical Center and an assistant professor of medicine at Harvard Medical School. Maisel was a vocal advocate for better safety measures and FDA reform in the wake of the recall of the Sprint Fidelis ICD lead recall.